Biomarin Pharmaceutical Inc SEC filings BMRN
Biomarin Pharmaceutical Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 2, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 4, 2026 | — |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2026 | Oct 6, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 30, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 3 | Initial insider ownership | Sep 14, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 31, 2026 | Aug 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 18, 2026 | Aug 17, 2026 |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K/A |
Amended current report
Other events
|
Jul 13, 2026 | Apr 27, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 144 | Notice of proposed sale | May 7, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Other events
|
Apr 23, 2026 | Apr 23, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 19, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 11, 2026 | — |
| 4 | Insider transaction | Feb 26, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 25, 2026 |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 23, 2026 | Feb 23, 2026 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 5 | Annual insider ownership | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 26, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 3 | Initial insider ownership | Jan 22, 2026 | Jan 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 22, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Dec 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 7, 2025 | Oct 7, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 3 | Initial insider ownership | Aug 5, 2025 | Aug 1, 2025 |
| S-8 | Employee stock plan registration | Aug 5, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2025 | Jul 30, 2025 |
| SC TO-T/A | Filing | Jul 1, 2025 | — |
| SC TO-T/A | Filing | Jun 17, 2025 | — |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| SC TO-T/A | Filing | Jun 13, 2025 | — |
| SC TO-T/A | Filing | Jun 4, 2025 | — |
| SC TO-T | Filing | Jun 2, 2025 | — |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| SC TO-C | Filing | May 19, 2025 | — |
| SC TO-C | Filing | May 19, 2025 | — |
| SC TO-C | Filing | May 16, 2025 | — |
| SC TO-C | Filing | May 16, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 16, 2025 | May 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 10-Q | Quarterly report | May 2, 2025 | Mar 31, 2025 |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| ARS | Annual report to shareholders | Apr 8, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 8, 2025 | — |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 20, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| 144 | Notice of proposed sale | Mar 19, 2025 | — |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 6, 2025 |
| 3/A | Form 3/a | Mar 7, 2025 | Feb 24, 2025 |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 3, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 3 | Initial insider ownership | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2025 | Feb 20, 2025 |
| 10-K | Annual report | Feb 24, 2025 | Dec 31, 2024 |
| 144 | Notice of proposed sale | Feb 24, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 19, 2025 | Feb 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| UPLOAD | Letter from the SEC | Oct 3, 2024 | — |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Oct 1, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2024 | Sep 24, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 13, 2024 |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 4, 2024 | Aug 28, 2024 |
| UPLOAD | Letter from the SEC | Sep 2, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs
|
Aug 28, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 15, 2024 | Aug 13, 2024 |
| 144 | Notice of proposed sale | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 3, 2024 |
| 144 | Notice of proposed sale | Jun 4, 2024 | — |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 144 | Notice of proposed sale | May 31, 2024 | — |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 144 | Notice of proposed sale | May 30, 2024 | — |
| 144 | Notice of proposed sale | May 30, 2024 | — |
| 144 | Notice of proposed sale | May 30, 2024 | — |
| 144 | Notice of proposed sale | May 29, 2024 | — |
| 144 | Notice of proposed sale | May 28, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 3 | Initial insider ownership | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 17, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Novato, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1048477
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.